Uvarigranol FCAS# 176598-10-0 |
Quality Control & MSDS
Number of papers citing our products
Chemical structure
3D structure
Cas No. | 176598-10-0 | SDF | Download SDF |
PubChem ID | 74315891.0 | Appearance | Powder |
Formula | C23H22O8 | M.Wt | 426.42 |
Type of Compound | Aliphatics | Storage | Desiccate at -20°C |
Solubility | Soluble in Chloroform,Dichloromethane,Ethyl Acetate,DMSO,Acetone,etc. | ||
Chemical Name | [5-(acetyloxymethyl)-4-benzoyloxy-5,6-dihydroxycyclohex-2-en-1-yl] benzoate | ||
SMILES | CC(=O)OCC1(C(C=CC(C1O)OC(=O)C2=CC=CC=C2)OC(=O)C3=CC=CC=C3)O | ||
Standard InChIKey | LVQXSADIPBMJHN-UHFFFAOYSA-N | ||
Standard InChI | InChI=1S/C23H22O8/c1-15(24)29-14-23(28)19(31-22(27)17-10-6-3-7-11-17)13-12-18(20(23)25)30-21(26)16-8-4-2-5-9-16/h2-13,18-20,25,28H,14H2,1H3 | ||
General tips | For obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20℃ for several months. We recommend that you prepare and use the solution on the same day. However, if the test schedule requires, the stock solutions can be prepared in advance, and the stock solution must be sealed and stored below -20℃. In general, the stock solution can be kept for several months. Before use, we recommend that you leave the vial at room temperature for at least an hour before opening it. |
||
About Packaging | 1. The packaging of the product may be reversed during transportation, cause the high purity compounds to adhere to the neck or cap of the vial.Take the vail out of its packaging and shake gently until the compounds fall to the bottom of the vial. 2. For liquid products, please centrifuge at 500xg to gather the liquid to the bottom of the vial. 3. Try to avoid loss or contamination during the experiment. |
||
Shipping Condition | Packaging according to customer requirements(5mg, 10mg, 20mg and more). Ship via FedEx, DHL, UPS, EMS or other couriers with RT, or blue ice upon request. |
Uvarigranol F Dilution Calculator
Uvarigranol F Molarity Calculator
1 mg | 5 mg | 10 mg | 20 mg | 25 mg | |
1 mM | 2.3451 mL | 11.7255 mL | 23.4511 mL | 46.9021 mL | 58.6276 mL |
5 mM | 0.469 mL | 2.3451 mL | 4.6902 mL | 9.3804 mL | 11.7255 mL |
10 mM | 0.2345 mL | 1.1726 mL | 2.3451 mL | 4.6902 mL | 5.8628 mL |
50 mM | 0.0469 mL | 0.2345 mL | 0.469 mL | 0.938 mL | 1.1726 mL |
100 mM | 0.0235 mL | 0.1173 mL | 0.2345 mL | 0.469 mL | 0.5863 mL |
* Note: If you are in the process of experiment, it's necessary to make the dilution ratios of the samples. The dilution data above is only for reference. Normally, it's can get a better solubility within lower of Concentrations. |
Calcutta University
University of Minnesota
University of Maryland School of Medicine
University of Illinois at Chicago
The Ohio State University
University of Zurich
Harvard University
Colorado State University
Auburn University
Yale University
Worcester Polytechnic Institute
Washington State University
Stanford University
University of Leipzig
Universidade da Beira Interior
The Institute of Cancer Research
Heidelberg University
University of Amsterdam
University of Auckland
TsingHua University
The University of Michigan
Miami University
DRURY University
Jilin University
Fudan University
Wuhan University
Sun Yat-sen University
Universite de Paris
Deemed University
Auckland University
The University of Tokyo
Korea University
- 3-Hydroxy-3-methylpentanedioic acid
Catalog No.:BCX1576
CAS No.:503-49-1
- Gelsemicine
Catalog No.:BCX1575
CAS No.:6887-28-1
- Hydroxyl-γ-isosanshool
Catalog No.:BCX1574
CAS No.:127514-62-9
- Uridine diphosphate xylose
Catalog No.:BCX1573
CAS No.:3616-06-6
- Uridine diphosphate rhamnose
Catalog No.:BCX1572
CAS No.:1955-26-6
- Trisodium UDP-glucuronic acid
Catalog No.:BCX1571
CAS No.:63700-19-6
- Escin Ie
Catalog No.:BCX1570
CAS No.:1613506-26-5
- α-Sanshool
Catalog No.:BCX1569
CAS No.:504-97-2
- 18α-Glycyrrhetinic acid Monoglucuronide
Catalog No.:BCX1568
CAS No.:400870-85-1
- Pinocembrin 7-O-[4'',6''-hexahydroxydiphenoyl]-β-D-glucoside
Catalog No.:BCX1567
CAS No.:205370-58-7
- Lutein distearate
Catalog No.:BCX1566
CAS No.:86852-15-5
- Lutein myristate palmitate
Catalog No.:BCX1565
CAS No.:104784-49-8
- 2'-Deoxyadenosine monohydrate
Catalog No.:BCX1578
CAS No.:16373-93-6
- 3-epi-Pumiloside
Catalog No.:BCX1579
CAS No.:126624-21-3
- Saikogenin A
Catalog No.:BCX1580
CAS No.:5092-09-1
- Methyl pentadecanoate
Catalog No.:BCX1581
CAS No.:7132-64-1
- Phosphatidylserine
Catalog No.:BCX1582
CAS No.:51446-62-9
- 4-(3-Oxobutyl)phenyl 6-O-[(2E)-3-phenyl-2-propenoyl]-2-O-(3,4,5-trihydroxybenzoyl)-β-D-glucopyranoside
Catalog No.:BCX1583
CAS No.:356517-93-6
- Bacdanol
Catalog No.:BCX1584
CAS No.:28219-61-6
- β-Sanshool
Catalog No.:BCX1585
CAS No.:10076-00-3
- Timosaponin H1
Catalog No.:BCX1586
CAS No.:288142-06-3
- Trikamsteroside A
Catalog No.:BCX1587
CAS No.:942916-76-9
- Thalictricoside
Catalog No.:BCX1588
CAS No.:649758-25-8
- HuangjiangSu A
Catalog No.:BCX1589
CAS No.:1026020-27-8
A divergent and stereoselective approach for the syntheses of (-)-zeylenol, (+)-6-O-benzoylzeylenol, (+)-uvarigranol E and (+)-uvarigranol F.[Pubmed:34530378]
Carbohydr Res. 2021 Nov;509:108432.
A common, divergent, efficient, and stereoselective approach to the total syntheses of four carbasugars, namely, (-)-zeylenol, (+)-6-O-benzoylzeylenol, (+)-uvarigranol E and (+)-Uvarigranol F from d-mannose derived key intermediate 14 is described. This intermediate was synthesized using mixed aldol condensation, Grignard reaction and ring closing metathesis as key steps by our previous method in nine steps from d-mannose. From this intermediate, we achieved the syntheses of (+)-6-O-benzoylzeylenol, (+)-Uvarigranol F in three steps, (+)-uvarigranol E in four steps and improved synthesis of (-)-zeylenol.